ustekinumab

U1S1T1E1K5I1N1U1M3A1B3

noun

A human monoclonal antibody directed against interleukin 12 and interleukin 23, in clinical trials for multiple sclerosis, psoriasis, and psoriatic arthritis.

Scrabble 19
Ask AI about this wordChatGPTClaudePerplexityGoogle AIGrok

Meanings

nounustekinumab (uncountable)
  1. uncountablemedicineA human monoclonal antibody directed against interleukin 12 and interleukin 23, in clinical trials for multiple sclerosis, psoriasis, and psoriatic arthritis.

    As another interleukin 12/23 antagonist, briakinumab, was withdrawn from further development in part due to concerns about cardiovascular safety, discussion has also emerged on cardiovascular safety of ustekinumab.

    2015 December 4, “Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients”, in PLOS ONE, →DOI

Origin

From -kin- (“interleukin”) + -umab (“human monoclonal antibody”).

Full word history & related roots →
Cite this entry
APA

ustekinumab. (n.d.). In WatkinsX Dictionary. Retrieved November 4, 2026, from https://dictionary.watkinsx.com/word/ustekinumab

MLA

“ustekinumab.” WatkinsX Dictionary, https://dictionary.watkinsx.com/word/ustekinumab. Accessed November 4, 2026.

Chicago

WatkinsX Dictionary, s.v. “ustekinumab,” accessed November 4, 2026, https://dictionary.watkinsx.com/word/ustekinumab.

Source: ustekinumab on Wiktionary, CC BY-SA 4.0.